[XENE] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
09-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- -20.58%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 9,434 18,437 32,166 6,829 0 311 1,803 31.74%
PBT -125,255 -78,888 -29,094 -41,618 -34,497 -30,704 -22,997 32.62%
Tax 118 -6 -257 -23 4,913 -1,871 -1,820 -
NP -125,373 -78,882 -28,837 -41,595 -34,497 -30,704 -22,997 32.64%
Tax Rate - - - - - - - -
Total Cost 134,807 97,319 61,003 48,424 34,497 31,015 24,800 32.58%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -1,328.95 -427.85 -89.65 -609.09 0.00 -9,872.67 -1,275.49 0.68%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -2.07 -1.81 -0.83 -1.60 -1.78 -1.71 -1.48 5.74%
EPS Diluted -2.07 -1.81 -0.83 -1.60 -1.78 -1.71 -1.48 5.74%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.